Dr Daniel Larorre, medical physicist at Central University Hospital of Asturias, presenting the latest ORIGIN research on the development of an in-vivo dosimeter for brachytherapy.Â
ORIGIN research showcased at Flanders Make
Dr Agnieszka Gierej presented her work on the design and fabrication of the ORIGIN optical fibre sensors at the Flanders Make conference in Antwerp.
ORIGIN researchers receive “Commitment to Research” award
Congratulations to ORIGIN consortium partners Galway Clinic on winning the Blackrock Health group “Commitment to Research” award in recognition of their innovative research #ORIGINProject #CancerResearch #ImprovingPatientOutcomes
ORIGIN at ECMP
ECMP is a major event in the calendar of medical physicists and ORIGIN was delighted to have the opportunity to present ORIGIN results “Pre-clinical characterisation of optical fibre sensors in HDR brachytherapy”.
Review Article in BJR
In this article, ORIGIN researcher Dr Orla Houlihan describes the potential role for in vivo dosimetry in the reduction of uncertainties in pelvic brachytherapy, the pertinent factors for consideration in clinical practice, and the future potential for in vivo dosimetry in the personalisation of brachytherapy.Â
ORIGIN at BGCS 2022
ORIGIN researcher Dr Orla Houlihan highlighted the role for personalised brachytherapy treatment in cervical cancer at the Annual Scientific Meeting of the British Gynaecological Cancer Society in London. Dr Houlihan’s recent review emphasises the clinical need for in vivo dosimetry to monitor radiation dose and radioactive source location in real-time.
ORIGIN at ICHEP 2022
Dr Agnese Giaz from the University of Insubria recently presented the work of ORIGN at ICHEP, the cornerstone event for the scientific community involved in high energy physics. Dr Giaz described how ORIGIN will provide Real-time 3D dose imaging and source localisation in brachytherapy and gave an overview of the commissioning and first results of a 16-sensor prototype.Â
Photonics Partnership Annual Meeting
ORIGIN was delighted to have the opportunity to contribute to the new Strategic Research and Innovation Agenda at the Photonics Partnership Annual Meeting in Brussels. Coordinator Dr Sinéad O’Keeffe presented an update on the ORIGIN project and joined in discussions to shape the future of photonics research in health.
ORIGIN raises €1,120 for Irish Cancer Society
ORIGIN is delighted to announce that over €1000 was raised for the Irish Cancer Society in response to the VHI women’s mini marathon fundraising event.
ORIGIN researchers joined over 20,000 women on the start line in Dublin this June to raise awareness of gynaecological cancer, promote women in STEMM and raise vital funds for the Irish cancer society.
A massive thank you to everyone who donated and super well done to all who took part on the day. Special thanks to Agnese Giaz, who travelled from Italy for the race!
#lCancerResearch #WomenMakingMagic
ORIGIN video launched
Check out ORIGIN’s video which describes how ORIGIN will lead to more effective and precise brachytherapy for the treatment of prostate and gynaecological cancer.
